Rólunk
Medical Doctor | Cancer Researcher | Entrepreneur
As a medical doctor, I translate…
Tevékenység
-
It was an absolute pleasure to give the keynote presentation at the AACR Special Conference on Optimizing Therapeutic Efficacy and Tolerability…
It was an absolute pleasure to give the keynote presentation at the AACR Special Conference on Optimizing Therapeutic Efficacy and Tolerability…
Kedvelte: Daniel Veres MD PhD
-
The future of targeted cancer therapies is shaping around Antibody-Drug Conjugates (ADCs). I had the pleasure of joining Eleni Tokali from GlobalData…
The future of targeted cancer therapies is shaping around Antibody-Drug Conjugates (ADCs). I had the pleasure of joining Eleni Tokali from GlobalData…
Megosztotta: Daniel Veres MD PhD
-
AstraZeneca and Stanford Medicine have entered into a strategic collaboration to accelerate drug discovery and development through AI and innovative…
AstraZeneca and Stanford Medicine have entered into a strategic collaboration to accelerate drug discovery and development through AI and innovative…
Kedvelte: Daniel Veres MD PhD
Szakmai tapasztalat
Tanulmányok
Kitüntetések és díjak
-
Forbes 30u30
-
Nyelvek
-
English
Jó szakmai nyelvismeret
-
German
Korlátozott szakmai nyelvismeret
-
Hungarian
Anyanyelvi vagy kétnyelvű szintű nyelvismeret
More activity by Daniel
-
At AstraZeneca, we continue to advance our computational pathology approaches to accelerate Oncology R&D and help ensure that patients receive the…
At AstraZeneca, we continue to advance our computational pathology approaches to accelerate Oncology R&D and help ensure that patients receive the…
Kedvelte: Daniel Veres MD PhD
-
View my verified achievement from Tableau.
View my verified achievement from Tableau.
Kedvelte: Daniel Veres MD PhD
-
🎉 New fundraising: We now cumulate $ 1️⃣0️⃣0️⃣ million in funding and expand to London 🇬🇧 🎉 I am beyond excited to share that AQEMIA raised…
🎉 New fundraising: We now cumulate $ 1️⃣0️⃣0️⃣ million in funding and expand to London 🇬🇧 🎉 I am beyond excited to share that AQEMIA raised…
Kedvelte: Daniel Veres MD PhD
-
The Festival of Genomics has been a mainstay on our calendar for quite a few years now. Look forward to another productive one in the new year where…
The Festival of Genomics has been a mainstay on our calendar for quite a few years now. Look forward to another productive one in the new year where…
Kedvelte: Daniel Veres MD PhD
-
🎙️ Join our webinar co-hosted with Accenture: New technologies to accelerate ADC design! Antibody-drug conjugates (ADCs) are transforming cancer…
🎙️ Join our webinar co-hosted with Accenture: New technologies to accelerate ADC design! Antibody-drug conjugates (ADCs) are transforming cancer…
Kedvelte: Daniel Veres MD PhD
-
We are thrilled and honored to be among the nominees for the #FutureUnicornAward! Huge thanks to the organizers and the incredible network behind…
We are thrilled and honored to be among the nominees for the #FutureUnicornAward! Huge thanks to the organizers and the incredible network behind…
Kedvelte: Daniel Veres MD PhD
-
The ADC combination space is growing at an unprecedented rate, with a 21.5% compound annual growth rate in trials over the past decade. This surge…
The ADC combination space is growing at an unprecedented rate, with a 21.5% compound annual growth rate in trials over the past decade. This surge…
Kedvelte: Daniel Veres MD PhD
-
Honored to share that Turbine has been selected as a finalist for MSD's Innovation Award of the Citeline Scrip Awards 2024. Congratulations to…
Honored to share that Turbine has been selected as a finalist for MSD's Innovation Award of the Citeline Scrip Awards 2024. Congratulations to…
Kedvelte: Daniel Veres MD PhD
-
Did you know over 100 ADC programs have been discontinued due to unresolved challenges like toxicity and resistance? The future of ADC development…
Did you know over 100 ADC programs have been discontinued due to unresolved challenges like toxicity and resistance? The future of ADC development…
Kedvelte: Daniel Veres MD PhD